Variant report

Variant	nsv947895
Chromosome Location	chr10:43458614-43488164
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr10:43474055-43474377	K562	blood:	n/a	n/a
2	ATF1	chr10:43474747-43475125	K562	blood:	n/a	n/a
3	BHLHE40	chr10:43476829-43477169	K562	blood:	n/a	chr10:43476970-43476986
4	BHLHE40	chr10:43484487-43484837	K562	blood:	n/a	n/a
5	CCNT2	chr10:43476863-43477053	K562	blood:	n/a	n/a
6	CEBPB	chr10:43477134-43477208	K562	blood:	n/a	n/a
7	CEBPB	chr10:43468469-43468786	HepG2	liver:	n/a	chr10:43468625-43468636 chr10:43468624-43468637
8	CEBPB	chr10:43467355-43467475	IMR90	lung:	n/a	n/a
9	CEBPB	chr10:43474862-43474980	K562	blood:	n/a	n/a
10	CEBPB	chr10:43468559-43468690	K562	blood:	n/a	chr10:43468625-43468636 chr10:43468624-43468637
11	CHD2	chr10:43471209-43471243	HepG2	liver:	n/a	n/a
12	CTCF	chr10:43471200-43471350	GM12865	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
13	CTCF	chr10:43470740-43470890	NB4	blood:	n/a	n/a
14	CTCF	chr10:43470912-43471570	HCT-116	colon:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
15	CTCF	chr10:43471088-43471416	MCF-7	breast:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
16	CTCF	chr10:43471180-43471276	SK-N-SH_RA	brain:	n/a	n/a
17	CTCF	chr10:43471220-43471370	HEK293	kidney:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
18	CTCF	chr10:43475960-43476110	WERI-Rb-1	eye:	n/a	n/a
19	CTCF	chr10:43471320-43471470	A549	lung:	n/a	n/a
20	CTCF	chr10:43475300-43475530	BE2_C	brain:	n/a	n/a
21	CTCF	chr10:43471200-43471350	HL-60	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
22	CTCF	chr10:43471200-43471350	K562	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
23	CTCF	chr10:43471200-43471350	HMEC	breast:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
24	CTCF	chr10:43471144-43471346	A549	lung:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
25	CTCF	chr10:43471072-43471434	K562	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
26	CTCF	chr10:43471129-43471397	Gliobla	brain:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
27	CTCF	chr10:43471072-43471551	MCF-7	breast:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
28	CTCF	chr10:43471114-43471407	MCF-7	breast:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
29	CTCF	chr10:43471156-43471370	Hela-S3	cervix:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
30	CTCF	chr10:43471160-43471310	SK-N-SH_RA	brain:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
31	CTCF	chr10:43471180-43471329	ProgFib	skin:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
32	CTCF	chr10:43471175-43471364	H1-hESC	embryonic stem cell:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
33	CTCF	chr10:43471180-43471330	NHEK	skin:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
34	CTCF	chr10:43471320-43471470	GM12870	blood:	n/a	n/a
35	CTCF	chr10:43471180-43471330	Caco-2	colon:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
36	CTCF	chr10:43471180-43471330	GM12865	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
37	CTCF	chr10:43471200-43471350	HepG2	liver:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
38	CTCF	chr10:43471140-43471290	HCT-116	colon:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
39	CTCF	chr10:43471169-43471364	HepG2	liver:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
40	CTCF	chr10:43471160-43471310	HMEC	breast:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
41	CTCF	chr10:43466200-43466350	BE2_C	brain:	n/a	n/a
42	CTCF	chr10:43471180-43471330	AG04449	skin:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
43	CTCF	chr10:43471192-43471328	GM19238	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
44	CTCF	chr10:43471178-43471358	GM12892	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
45	CTCF	chr10:43471200-43471350	GM06990	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
46	CTCF	chr10:43471200-43471350	NB4	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
47	CTCF	chr10:43471200-43471350	GM12875	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
48	CTCF	chr10:43471220-43471370	GM12866	blood:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
49	CTCF	chr10:43471160-43471310	HFF-Myc	foreskin:	n/a	chr10:43471275-43471283 chr10:43471268-43471286
50	CTCF	chr10:43471180-43471330	BE2_C	brain:	n/a	chr10:43471275-43471283 chr10:43471268-43471286

No.	Distal block	Cell Line	Cell type
1	chr10:43454488..43457151-chr10:43458866..43460532,2	K562	blood:
2	chr10:43477135..43480872-chr10:43482623..43485089,4	MCF-7	breast:
3	chr10:43465926..43467640-chr10:43469651..43471316,2	K562	blood:
4	chr10:43465926..43467640-chr10:43469651..43471316,2	K562	blood:
5	chr10:43469169..43471779-chr10:43471792..43473949,2	K562	blood:
6	chr10:43486095..43489357-chr10:43490017..43492485,3	MCF-7	breast:
7	chr10:43481086..43483555-chr10:43520776..43523098,2	MCF-7	breast:
8	chr10:43470988..43471723-chr10:43574194..43574824,2	MCF-7	breast:
9	chr10:43442278..43444933-chr10:43480874..43482921,2	K562	blood:
10	chr10:43471587..43474099-chr10:43476210..43479281,3	MCF-7	breast:
11	chr10:43469610..43472857-chr10:43520371..43524809,5	MCF-7	breast:
12	chr10:43467866..43472352-chr10:43571131..43575180,5	MCF-7	breast:
13	chr10:43470043..43470710-chr4:7069530..7070337,2	NB4	blood:
14	chr10:43487519..43490099-chr10:43491819..43493663,2	MCF-7	breast:
15	chr10:43472744..43475645-chr10:43482853..43485433,2	K562	blood:
16	chr10:43472048..43472812-chr11:819441..820070,2	NB4	blood:
17	chr10:43361867..43362389-chr10:43470791..43471531,2	K562	blood:
18	chr10:43471183..43472148-chr4:106629910..106630418,2	NB4	blood:
19	chr10:43474227..43476529-chr10:43479652..43481353,2	MCF-7	breast:
20	chr10:43365868..43366659-chr10:43470638..43471752,5	MCF-7	breast:
21	chr10:43474536..43476774-chr10:43520389..43522895,3	MCF-7	breast:
22	chr10:43482866..43485744-chr10:43490374..43493373,2	K562	blood:
23	chr10:43474227..43476529-chr10:43479652..43481353,2	MCF-7	breast:
24	chr10:43463562..43467082-chr10:43469575..43473842,3	MCF-7	breast:
25	chr10:43484291..43485932-chr10:43488466..43491187,2	MCF-7	breast:
26	chr10:43458559..43459070-chr17:7387320..7387822,2	NB4	blood:
27	chr10:43454969..43457476-chr10:43464603..43467508,2	MCF-7	breast:
28	chr10:43361913..43362690-chr10:43470789..43471679,3	MCF-7	breast:
29	chr10:43469169..43471779-chr10:43471792..43473949,2	K562	blood:
30	chr10:43472378..43475581-chr10:43520718..43522410,3	MCF-7	breast:
31	chr10:43471160..43472154-chr11:102217419..102218246,2	NB4	blood:
32	chr10:43369343..43371320-chr10:43469616..43472165,2	MCF-7	breast:
33	chr1:113932116..113933106-chr10:43470154..43470896,2	NB4	blood:
34	chr10:43361871..43362799-chr10:43470867..43471733,6	MCF-7	breast:
35	chr10:43477135..43480872-chr10:43482623..43485089,4	MCF-7	breast:
36	chr10:43471330..43471857-chr3:38035458..38036022,2	NB4	blood:
37	chr10:43472744..43475645-chr10:43482853..43485433,2	K562	blood:
38	chr10:43463562..43467082-chr10:43469575..43473842,3	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RASGEF1A-1	chr10:43475731-43476007	XLOC_008790
2	lnc-RET-2	chr10:43482124-43482459	NONHSAT012938
3	lnc-RET-2	chr10:43481122-43481247	NONHSAT012938
4	lnc-RET-3	chr10:43487762-43487899	ucscGeneNc_uc001jba_2
5	lnc-RASGEF1A-1	chr10:43476816-43476955	XLOC_008790
6	lnc-RET-3	chr10:43487172-43487532	ucscGeneNc_uc001jba_2
7	lnc-RASGEF1A-1	chr10:43474465-43474547	XLOC_008790
8	lnc-RET-3	chr10:43486575-43486975	ucscGeneNc_uc001jba_2

Variant related genes	Relation type
MIR5100	TF binding region
ENSG00000229630	TF binding region
ENSG00000110330	chromatin interactions
ENSG00000109519	chromatin interactions
ENSG00000165731	chromatin interactions
ENSG00000136059	chromatin interactions
ENSG00000138785	chromatin interactions
ENSG00000229630	chromatin interactions
ENSG00000174282	chromatin interactions
ENSG00000181222	chromatin interactions
ENSG00000138780	chromatin interactions
ENSG00000263795	chromatin interactions

Extended variants
information (count: 1265 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:1265 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs560648668	chr10:43458618-43458619	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs534026410	chr10:43458621-43458622	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs540000803	chr10:43458628-43458629	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs565037571	chr10:43458650-43458651	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs372346984	chr10:43458661-43458662	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs532408261	chr10:43458664-43458665	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs386743156	chr10:43458668-43458669	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs141745031	chr10:43458718-43458719	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs530319676	chr10:43458737-43458738	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs77478502	chr10:43458738-43458739	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs530112582	chr10:43458749-43458750	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs114810684	chr10:43458773-43458774	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs116295229	chr10:43458776-43458777	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs190775261	chr10:43458850-43458851	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs114591642	chr10:43458876-43458877	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs61845264	chr10:43458888-43458889	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs538562427	chr10:43458900-43458901	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs371030742	chr10:43458928-43458929	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs536405430	chr10:43458943-43458944	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs556452586	chr10:43458949-43458950	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs369317538	chr10:43459078-43459079	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs535837160	chr10:43459094-43459095	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs143851606	chr10:43459097-43459098	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs554257384	chr10:43459106-43459107	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs2995395	chr10:43459126-43459127	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs184052775	chr10:43459133-43459134	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs187452086	chr10:43459152-43459153	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs576950050	chr10:43459171-43459172	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs77296948	chr10:43459188-43459189	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs3121318	chr10:43459204-43459205	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs530124855	chr10:43459255-43459256	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs79987588	chr10:43459265-43459266	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs192794892	chr10:43459306-43459307	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs182984297	chr10:43459345-43459346	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs187265828	chr10:43459386-43459387	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs552373339	chr10:43459404-43459405	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs571050806	chr10:43459446-43459447	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs538054318	chr10:43459470-43459471	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs371015272	chr10:43459505-43459506	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs550493186	chr10:43459513-43459514	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs568376993	chr10:43459536-43459537	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs138782164	chr10:43459566-43459567	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs554116536	chr10:43459569-43459570	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs569936585	chr10:43459584-43459585	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs566245335	chr10:43459588-43459589	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs533923366	chr10:43459597-43459598	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs141850068	chr10:43459617-43459618	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs1970954	chr10:43459637-43459638	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs544036383	chr10:43459662-43459663	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs369991734	chr10:43459668-43459669	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Autism	18414403	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Mental retardation	21062444	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Testicular germ cell tumor	18059402	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	22241247	CNVD
Intellectual disability	21811512	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Obesity	21956041	CNVD
Renal cell carcinoma	18765545	CNVD
Breast cancer	21785460	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21948486	CNVD
Dysmorphic features	21948486	CNVD
Epilepsy	21948486	CNVD
Breast cancer	21509527	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:179 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:43453400-43459200	Enhancers	Fetal Muscle Leg	muscle
2	chr10:43454800-43458800	Enhancers	Fetal Muscle Trunk	muscle
3	chr10:43455800-43460200	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr10:43456400-43459400	Enhancers	Adipose Nuclei	Adipose
5	chr10:43456600-43461800	Weak transcription	H1 Cell Line	embryonic stem cell
6	chr10:43456800-43459000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr10:43457400-43459600	Enhancers	Primary neutrophils fromperipheralblood	blood
8	chr10:43457400-43459800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr10:43458000-43459600	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr10:43458200-43458800	Enhancers	Primary hematopoietic stem cells	blood
11	chr10:43458400-43459200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr10:43458600-43459600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
13	chr10:43458600-43464800	Weak transcription	HUES6 Cell Line	embryonic stem cell
14	chr10:43458600-43464800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
15	chr10:43459000-43459400	Enhancers	iPS-18 Cell Line	embryonic stem cell
16	chr10:43459000-43459400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr10:43459400-43460000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr10:43459600-43460000	Enhancers	Monocytes-CD14+_RO01746	blood
19	chr10:43460000-43460400	Weak transcription	Monocytes-CD14+_RO01746	blood
20	chr10:43460000-43461600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr10:43460200-43461600	Weak transcription	Primary monocytes fromperipheralblood	blood
22	chr10:43460400-43460600	Enhancers	Monocytes-CD14+_RO01746	blood
23	chr10:43460600-43465800	Weak transcription	Monocytes-CD14+_RO01746	blood
24	chr10:43461600-43462000	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr10:43461600-43462000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr10:43461800-43462000	Enhancers	H1 Cell Line	embryonic stem cell
27	chr10:43462000-43465800	Weak transcription	Primary monocytes fromperipheralblood	blood
28	chr10:43462000-43466000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr10:43464800-43465000	Enhancers	HUES6 Cell Line	embryonic stem cell
30	chr10:43464800-43466400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr10:43465000-43465400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr10:43465000-43465800	Weak transcription	HUES6 Cell Line	embryonic stem cell
33	chr10:43465400-43465600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr10:43465400-43466200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
35	chr10:43465600-43466000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr10:43465800-43466600	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr10:43465800-43467000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr10:43465800-43471200	Enhancers	Primary monocytes fromperipheralblood	blood
39	chr10:43465800-43471400	Enhancers	Monocytes-CD14+_RO01746	blood
40	chr10:43466000-43466600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
41	chr10:43466000-43466600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr10:43466000-43466800	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr10:43466000-43467000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr10:43466000-43471200	Enhancers	Primary neutrophils fromperipheralblood	blood
45	chr10:43466200-43466600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr10:43466200-43466800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr10:43466200-43467000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
48	chr10:43466200-43467000	Bivalent Enhancer	Fetal Muscle Leg	muscle
49	chr10:43466400-43466600	Enhancers	NHEK	skin
50	chr10:43466600-43466800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links